Abstract:DICER1 syndrome is a cancer predisposition syndrome where affected patients have increased risk of neoplasms including pleuropulmonary blastoma, Sertoli-Leydig cell tumor, and fusion-negative rhabdomyosarcoma (FN-RMS). This syndrome is defined by germline heterozygous loss of function mutations in the gene DICER1, but it remains unclear exactly how these mutations predispose children to develop cancer. One would expect the germline loss of one allele to provide a sensitized background in the tumor cell to acquire a second hit mutation. To gain insight into the role of Dicer1 loss in FN-RMS, we deleted the Dicer1 gene both globally in the germline and conditionally in the tumor cell in our previously established mouse model of FN-RMS. Surprisingly, we observed faster tumor onset and increased penetrance in mice with germline heterozygous Dicer1 loss (Dicer1+/-) but not in mice where Dicer1 loss was restricted to the tumor cells, demonstrating that Dicer1 functions as a non-cell autonomous haploinsufficient tumor suppressor. Single cell RNA sequencing (scRNA-Seq) revealed massive expansion of immature neutrophils in Dicer1+/- tumors, which were enriched for proteases associated with neutrophil extracellular traps (NETs). NETs are webs of chromatin and proteases released when neutrophils undergo NETosis in response to inflammatory stimuli. These NETs are known to cause significant damage to the local extracellular matrix (ECM) and have been implicated in tumor promotion. In addition to the neutrophil enriched immunophenotype, we found that Dicer1+/- tumors show significant ECM remodeling and are enriched for C5a, the potent neutrophil chemoattractant and NET-priming factor. Taken together, these results suggest NETosis is upregulated in Dicer1+/- FN-RMS tumors. Performing iTALK ligand-receptor pair analysis on the scRNA-Seq data revealed a putative interaction between a NET-derived ligand and EGFR and IGF1R on tumor cells, suggesting direct tumor promoting signaling from NET-to-tumor. We validated this novel FN-RMS promotion mechanism in vitro using human FN-RMS cell lines and observed that this NET-derived ligand promoted FN-RMS growth in a dose-dependent manner and could function through both EGFR and IGF1R signaling. Finally, we incorporated a Padi4-/- allele into our tumor model to genetically block NETosis and observed complete rescue of the accelerated tumor onset and increased penetrance observed in Dicer1+/- mice, demonstrating that NETosis promotes the growth of Dicer1+/- FN-RMS tumors. Importantly, these findings may be applicable to many DICER1 syndrome-associated cancers, as neutrophils which get converted to tumor promoters by heterozygous DICER1 loss are present in DICER1 syndrome patients regardless of tumor type. Citation Format: Randolph Larsen, Jason Hanna, Kristin Reed, Hongjian Jin, Wood Kimbrough, Kyna Vuong, Myron Evans, Casey Langdon, Catherine Drummond, Matthew Garcia, David Finkelstein, Patrick Schreiner, Jerold Rehg, Mark Hatley. Germline DICER1 loss promotes rhabdomyosarcoma via innate immune system [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 5463.

Two cases of primary supratentorial intracranial rhabdomyosarcoma with DICER1 mutation which may belong to a “spindle cell sarcoma with rhabdomyosarcoma-like feature, DICER1 mutant”

A Case of Primary Intracranial Sarcoma, DICER1-Mutant, in a Child with a Germline DICER1 Mutation

Primary intracranial sarcoma associated with DICER1 mutant: a case report and preclinical investigation

Primary intracranial spindle cell sarcoma with rhabdomyosarcoma-like features share a highly distinct methylation profile and DICER1 mutations

Recurrent primary intracranial sarcoma, DICER1-mutant in a pediatric patient with DICER1 syndrome: the importance of molecular testing

A Rare Adult Primary Intracranial Sarcoma, DICER1-Mutant Identified by Epigenomic Profiling: A Case Report

Primary intracranial sarcoma, DICER-1 mutant, with hemorrhagic presentation: A case report

DICER1-associated malignancies mimicking germ cell neoplasms: Report of two cases and review of the literature

Epco-09. Dicer1-Mutant Primary Intracranial Sarcoma: Assessing The Oncogenic Role Of Mirna Dysregulation

Imaging Features of Primary Intracranial Sarcoma with DICER1 Mutation: A Multicenter Case Series

Spatial single cell transcriptomic analysis of a novel DICER1 Syndrome GEMM informs the cellular origin and developmental hierarchy of associated sarcomas

DICER1 tumor predisposition syndrome: an evolving story initiated with the pleuropulmonary blastoma

DICER1-associated central nervous system sarcoma: A comprehensive clinical and genomic characterization of case series of young adult patients

Novel ATXN1/ATXN1L::NUTM2A Fusions Identified in Aggressive Infant Sarcomas with Gene Expression and Methylation Patterns Similar to CIC-rearranged Sarcoma

Abstract 5463: Germline DICER1 loss promotes rhabdomyosarcoma via innate immune system

Path-38. Intracranial Sarcoma With Dicer1 Mutation In A Patient With Neurofibromatosis Type 1

Novel pathogenic variant of DICER1 in an adolescent with multinodular goiter, ovarian Sertoli–Leydig cell tumor and pineal parenchymal tumor of intermediate differentiation

Histopathologic "Evolution" in Pediatric Primary Intracranial High-Grade Sarcoma - a Key that Unlocked the Correct Diagnosis

Clinical and Molecular Characteristics May Alter Treatment Strategies of Thyroid Malignancies in DICER1 Syndrome

Sertoli–Leydig tumor and DICER1 gene mutation: A case series and literature review

Testicular Sertoli cell tumour and potentially testicular Leydig cell tumour are features of DICER1 syndrome